MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2016-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pbb.2016.10.002PMID 27725273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ribosomopathies: how a common root can cause a tree of pathologies

  2015cited by this paper
• MDMA alters emotional processing and facilitates positive social interaction

  2014cited by this paper
• Introduction of the human AVPR1A gene substantially alters brain receptor expression patterns and enhances aspects of social behavior in transgenic mice

  2014cited by this paper
• xytocin and object preferences in the male prairie vole

  2014cited by this paper
• Animal research. Male scent may compromise biomedical studies.

  2014cited by this paper
• 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.

  2014cited by this paper
• Oxytocin and vasopressin modulate the social response to threat: a preclinical study.

  2014cited by this paper
• Chronic enhancement of brain oxytocin levels causes enduring anti-aggressive and pro-social explorative behavioral effects in male rats.

  2014cited by this paper
• Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats.

  2014cited by this paper
• MDMA enhances emotional empathy and prosocial behavior.

  2014cited by this paper
• Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor

  2013cited by this paper
• The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences.

  2013cited by this paper
• Oxytocin increases anxiety to unpredictable threat

  2013cited by this paper
• Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.

  2012cited by this paper
• Aggregation in quads but not pairs of rats exposed to cat odor or bright light.

  2012cited by this paper
• Chronic Subordinate Colony Housing (CSC) as a Model of Chronic Psychosocial Stress in Male Rats

  2012cited by this paper
• Do initial responses to drugs predict future use or abuse?

  2012cited by this paper
• Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

  2012cited by this paper
• Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat

  2012cited by this paper
• The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor‐Binding Profile, Prosocial Effects and Distribution of c‐Fos Expression in Adolescent Rats

  2012cited by this paper
• Breaking the loop: oxytocin as a potential treatment for drug addiction.

  2012cited by this paper
• Behavioural consequences of two chronic psychosocial stress paradigms: anxiety without depression.

  2012cited by this paper
• Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

  2011cited by this paper
• MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.

  2011cited by this paper
• Vasotocin neurons and septal V1a-like receptors potently modulate songbird flocking and responses to novelty.

  2011cited by this paper
• The Neuropeptide Oxytocin Facilitates Pro-Social Behavior and Prevents Social Avoidance in Rats and Mice

  2011cited by this paper
• Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent.

  2010cited by this paper
• Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

  2009cited by this paper
• Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats

  2009cited by this paper
• Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments.

  2007cited by this paper
• A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").

  2007cited by this paper
• The involvement of the vasopressin system in stress-related disorders.

  2006cited by this paper
• Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.

  2005cited by this paper
• What All Social Workers Should Know About MDMA (Ecstasy)

  2004cited by this paper
• Providing Culturally Specific Substance Abuse Services in Refugee and Immigrant Communities: Lessons from a Cambodian Treatment and Demonstration Project

  2004cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats.

  2003cited by this paper
• Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders

  2003cited by this paper
• Tickling induces reward in adolescent rats.

  2001cited by this paper
• The oxytocin receptor system: structure, function, and regulation.

  2001cited by this paper
• (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.

  2000cited by this paper
• Ecstasy (MDMA): a review of its possible persistent psychological effects

  2000cited by this paper
• Strain differences in open-field and elevated plus-maze behavior of rats without and with pretest handling.

  1998cited by this paper
• Low-dose MDMA ("ecstasy") induces vasopressin secretion.

  1998cited by this paper
• Oxytocin Administered Centrally Facilitates Formation of a Partner Preference in Female Prairie Voles (Microtus ochrogaster)

  1994cited by this paper
• The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms.

  1993cited by this paper
• Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

  1993cited by this paper
• The effect of handling rats on their growth and behaviour

  1965cited by this paper

• History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA).

  2025cites this paper
• The 3,4-methylenedioxymethamphetamine (MDMA) reduces prosocial behavior in the social preference test in male and female rats.

  2025cites this paper
• Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model

  2025cites this paper
• The psychedelic-peptide paradox: a hormetic hypothesis

  2025cites this paper
• Examining the Role of Oxytocinergic Signaling and Neuroinflammatory Markers in the Therapeutic Effects of MDMA in a Rat Model for PTSD

  2024cites this paper
• Contrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features

  2024cites this paper
• Naloxone increases conditioned fear responses during social buffering in male rats

  2024cites this paper
• Therapeutic mechanisms of psychedelics and entactogens

  2023cites this paper
• The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

  2023cites this paper
• Processing of auditory information in forebrain regions after hearing loss in adulthood: Behavioral and electrophysiological studies in a rat model

  2022cites this paper
• Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter‐mediated nonquantal dopamine release

  2021cites this paper
• A Systematic Review of the MDMA Model to Address Social Impairment in Autism

  2021cites this paper
• Arg-Vasotocin Directly Activates Isotocin Receptors and Induces COX2 Expression in Ovoviviparous Guppies

  2021influential citation
• Neurotransmitters and Hormones in Human Decision-Making

  2021cites this paper
• Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

  2020cites this paper
• Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication

  2018cites this paper
• Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects

  2018cites this paper
• Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

  2017cites this paper
• GRK2 Mediates Arginine Vasopressin-Induced Interleukin-6 Production via Nuclear Factor-κB Signaling Neonatal Rat Cardiac Fibroblast

  2017cites this paper
• GRK2/β‐arrestin mediates arginine vasopressin‐induced cardiac fibroblast proliferation

  2017cites this paper
• GRK2 mediates arginine vasopressin-induced IL-6 production via NF-k B signaling in neonatal rat cardiac fibroblasts

  2016cites this paper
• GRK 2 / β-arrestin mediates arginine vasopressin-induced cardiac fibroblast proliferation Running title : GRK 2 / β-arrestinmediates cell proliferation

  2016cites this paper
• Naloxone blocks social buffering of conditioned fear responses in rats

  year unknowncites this paper
• 15 Nonapeptide Evolution and the Regulation of Social Behaviour in Teleost Fish: From Molecules to Sociality

  year unknowncites this paper